Safety and Efficacy Study to Treat Recurrent Grade 4 Malignant Brain Tumors
Study Title
- Safety and Efficacy Study to Treat Recurrent Grade 4 Malignant Brain Tumors
Teva Identifier
- IXR-202-22-188
ClinicalTrials.gov Identifier
- NCT00104091
Study Status
- Completed
Trial Condition(s)
- Glioblastoma Multiforme
Interventions
- Drug: TP-38
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
Gender
- Female, Male
Age Range
- 18 Years and older
Trial Duration
- 12/01/2004 - 06/01/2007
Phase
- Phase 2
Study Type
Interventional
